EP 3355896 A2 20180808 - METHODS OF USING SMAD7 ANTISENSE OLIGONUCLEOTIDES BASED ON BIOMARKER EXPRESSION
Title (en)
METHODS OF USING SMAD7 ANTISENSE OLIGONUCLEOTIDES BASED ON BIOMARKER EXPRESSION
Title (de)
VERFAHREN ZUR VERWENDUNG VON SMAD7-ANTISENSE-OLIGONUKLEOTIDEN AUF DER BASIS VON BIOMARKEREXPRESSION
Title (fr)
MÉTHODES D'UTILISATION D'OLIGONUCLÉOTIDES ANTISENS SMAD7 SUR LA BASE DE L'EXPRESSION DE BIOMARQUEURS
Publication
Application
Priority
- US 201562235556 P 20150930
- EP 2016073518 W 20160930
Abstract (en)
[origin: WO2017055611A2] Described herein are methods of treating inflammatory bowel disease (IBD) in a patient having IBD using SMAD7 antisense oligonucleotides.
IPC 8 full level
A61K 31/712 (2006.01); A61P 1/00 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01)
CPC (source: EP)
A61K 31/7125 (2013.01); A61P 1/00 (2017.12); A61P 1/04 (2017.12); C12N 15/1136 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/3341 (2013.01); G01N 2333/4733 (2013.01); G01N 2333/5409 (2013.01); G01N 2333/5437 (2013.01); G01N 2800/065 (2013.01); G01N 2800/52 (2013.01)
Citation (search report)
See references of WO 2017055611A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017055611 A2 20170406; WO 2017055611 A3 20170831; WO 2017055611 A9 20170727; CA 3000569 A1 20170406; EP 3355896 A2 20180808; JP 2018531936 A 20181101
DOCDB simple family (application)
EP 2016073518 W 20160930; CA 3000569 A 20160930; EP 16778306 A 20160930; JP 2018516772 A 20160930